Month: June 2021

BREXAFEMME® (ibrexafungerp tablets), for oral useA novel oral antifungal approved for the treatment of vulvovaginal candidiasis (VVC), also known as vaginal yeast infectionBREXAFEMME, a one-day, novel, oral treatment for vaginal yeast infection, is the first FDA-approved indication of the ibrexafungerp antifungal development pipeline and the first approved drug from a novel antifungal class in over 20 years Commercial launch update call is scheduled for Tuesday, June 29th @ 12pm ETJERSEY CITY, N.J., June 23, 2021 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant fungal infections, today announced that it will present a commercial launch update for its recently FDA-approved drug, BREXAFEMME® (ibrexafungerp...

NEW YORK, June 23, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. To view the full publication, “A Lesson in Cannabis: Second Mover Can Be Better Position,” please visit: https://nnw.fm/VJcx0. Even though medical marijuana had been legal in some U.S. states for more than a decade, the substance didn’t gain much recognition until Colorado set the market on its head in 2012 by making adult-use marijuana legal. Since then, other states have followed suit, while in 2018, Canada went all-in to become the first developed nation with...

XB2001 Is a Novel Therapy that Interrupts Inflammation to Potentially Block Growth and Spread of Tumors and to Reduce Toxicity of Chemotherapy Treatment AUSTIN, Texas, June 23, 2021 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ: XBIT) has enrolled the first patient in its 1-BETTER study, a randomized, double-blind, placebo-controlled clinical study to evaluate XB2001 in combination chemotherapy for treatment of Pancreatic Cancer. XBiotech’s novel anti-cancer agent, XB2001, is being assessed in combination with ONIVYDE + 5-FU/LV chemotherapy regimens. Safety and tolerability of the regimen, as well as progression-free survival, overall survival and time-to-treatment-failure will be assessed in the study. XB2001 blocks inflammation pathways turned on by tumors that help tumors vascularize, spread and cause collateral damage to healthy...

NEW YORK, June 23, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Uranium Energy Corp. (NYSE American: UEC) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. To view the full publication, “Time to Capitalize on the Net Zero Emission Initiative,” please visit: https://nnw.fm/jtRjZ. Last month, the International Energy Agency (IEA) issued a comprehensive and actionable plan to cap the global temperature rise to 1.5°C by mid-century without upending energy stability, accessibility or pricing. IEA covers it all and lays out how renewable energies in combination with nuclear power will become the dominant energy sources across the planet even...

DANBURY, Conn., June 23, 2021 (GLOBE NEWSWIRE) — FuelCell Energy, Inc. (Nasdaq: FCEL) — a global leader in fuel cell technology with a purpose of utilizing its proprietary, state-of-the-art fuel cell platforms to enable a world empowered by clean energy— today announced that Betsy Schaefer joined its team as the new Chief Marketing Officer. Betsy brings a wealth of experience to FuelCell Energy having built a decorated career at IBM in corporate communications, marketing and brand management where she most recently led marketing for the Watson AI division. Betsy is an innovative and technology-focused marketing professional with extensive experience in crafting brand strategies, managing high performance teams and driving marketing initiatives. Her experience as a leader in product, performance content marketing, with expertise...

PSYC Examines Senate Bill 519 Which Aims to Decriminalize Psychedelics in California LAKE OSWEGO,OR, June 23, 2021 (GLOBE NEWSWIRE) — Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) a leading publicly traded digital media company within the emerging sector of medicinal psychedelics, is pleased to announce that the Company’s CEO, David Flores, recently sat down with CA Senator Scott Wiener (D-San Francisco) as part of an exclusive Psychedelic Spotlight interview to discuss Senate Bill 519 which aims to decriminalize the possession and sharing of certain hallucinogenic/psychedelic substances within the state. The measure, which was introduced by Senator Wiener earlier this year, cleared its first major hurdle this month when it was passed in a 21-16 vote by the state Senate resulting in it moving on...

Figure 1Crater Lake Drillhole Location MapFigure 2Diamond Drill Cross-Section 400N, TG Zone, Crater Lake Project, QuebecFigure 3Diamond Drill Cross-Section 600N, TG Zone, Crater Lake Project, QuebecHighlights:Assay results from the first four drillholes continue to return impressive intercepts of 99.8 m (327.3’) grading 299 g/t scandium oxide (Sc2O3), including 24.2 m (79.4’) grading 331 g/t Sc2O3 and 77.3 m (253.5′) grading 313 g/t Sc2O3. Elevated levels of total rare earth oxides plus yttrium (TREO+Y) of up to 0.46 % characterize the scandium-bearing intercepts.All drill assays have been received and the data has been transferred to our engineering group to complete the 43-101 resource estimation work on the TG Zone.MONTREAL, June 23, 2021 (GLOBE NEWSWIRE) — Imperial...

PEMBROKE, Bermuda, June 23, 2021 (GLOBE NEWSWIRE) — James River Group Holdings, Ltd. (“James River” or the “Company”) (NASDAQ: JRVR) today announced the retirement of Robert P. (Bob) Myron, President and Chief Operating Officer, after more than 11 years with the organization. Mr. Myron will retire effective July 31, 2021 for health reasons related to lingering effects of Lyme Disease. The Company and Mr. Myron expect to maintain a consulting relationship through December 31, 2021. Frank D’Orazio, the Company’s Chief Executive Officer, commented, “I’d like to thank Bob for his numerous contributions to the Company. He has led operations at every level of the Company, including as CEO and as a member of the Board of Directors. Throughout his distinguished tenure at James River, Bob has demonstrated outstanding leadership and dedication...

BRANFORD, Conn., June 23, 2021 (GLOBE NEWSWIRE) — Sachem Capital Corp. (NYSE American: SACH) today announced that it has commenced an underwritten public offering of its Series A Cumulative Redeemable Preferred Stock (the “Series A Preferred Stock”). The terms of the offering, including the number of shares to be offered and sold and the dividend rate are to be determined by negotiations between the Company and the underwriters. The Series A Preferred Stock has a private credit rating of ‘BBB’ from Egan-Jones Ratings Company, an independent unaffiliated rating agency. In addition, the Company plans to grant the underwriters a 30-day option to purchase additional shares of Series A Preferred Stock on the same terms and conditions to cover overallotments, if any. The Series A Preferred Stock is expected to be listed on the NYSE American...

SYRACUSE, N.Y., June 23, 2021 (GLOBE NEWSWIRE) — Carrols Restaurant Group, Inc. (NASDAQ: TAST) (“Carrols Restaurant Group”) announced today that it plans to offer, in a private placement, senior notes due 2029 in the aggregate principal amount of $300 million (the “Notes”). Carrols Restaurant Group is the largest U.S. Burger King® franchisee based on the number of restaurants and has owned and operated Burger King restaurants since 1976. As of April 4, 2021, the Company owned and operated 1,010 Burger King restaurants and 65 Popeyes® restaurants. Carrols Restaurant Group intends to use the net proceeds of the private placement of the Notes and $46 million of revolving credit borrowings under its senior credit facility (i) to repay $74.0 million of outstanding term loan B-1 borrowings and $244.0 million of outstanding term loan...